跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,060 条关于
“Per2”
全部
5,060
临床试验
4,362
药物
224
机构
20
资讯
454
去年
ARBs' Antihypertensive Effects Linked to Gut Microbiota Modulation
去年
Glioblastoma Tumors Exploit Circadian Rhythms to Accelerate Growth
去年
IBI354 Demonstrates Promising Efficacy and Tolerability in HER2-Positive and HER2-Low Breast Cancer
去年
Enhertu Approved for HER2-Low and HER2-Ultralow Metastatic Breast Cancer
去年
3D Pathology Technology Reclassifies 67% of HER2-Null Breast Cancer Cases as HER2-Expressing
去年
Trastuzumab Deruxtecan Shows Promise in HER2-Overexpressing NSCLC
去年
HER2-Targeted Therapies Solidify Role in Early-Stage HER2-Positive Breast Cancer Treatment
去年
Evorpacept Plus Zanidatamab Shows Promise in HER2-Positive and HER2-Low Metastatic Breast Cancer
7个月前
Innovent Initiates Phase 3 Trial of IBI354 HER2 ADC for First-Line HER2-Positive Breast Cancer Treatment
3个月前
HER2-LADDER: A Spatially Interpretable AI Framework Predicts Neoadjuvant Dual HER2-Targeted Therapy Response in Breast Cancer
第 1 页,共 46 页
上一页
下一页